List of Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
List of Authors
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Orlando Lòpez
Jennifer L'Hote Gaston
L. Sampath Kumar
Geriene LaBine
DPT Laboratories
Triclinic Labs, Inc.
Jeff Lagrange
Jin-Wang Lai
Samantha Lai
Ajay R. Lajmi
Dr. A.D. lakdawala
A.D. lakdawala
Rick Lake
Aikaterini Lalatsa, PhD
Anita Lalwani
Michael D Lam
Philippe Lam
Peter Lambert
Dr. Ronald R. Lamonte
Ian Lancaster
Lancaster Laboratories
Chad A. Landmon
Lang Lang
Qingyong Lang
Beth A. Langdon
Gerd Langenbucher
Eric Langer
Peter Langguth
Ken Langhorn
Matt Langie
A. LaPaglia
Erika Lapinskas
Jaqueline Larew
KIMBERLY-CLARK PROFESSIONAL (Damon Larkin)
Damon Larkin
Gregory Larner
Paul Larocque
Michael Larson
George Laurence
Alice Laures
Corrine Lawrence
Jeanne Lawson
Buddhadev Layek
Mark Leaper
Alain Leblanc
David LeBlond
Albert Lee
Albert S. Lee
John Lee
John Y. Lee
John V. Lee
P. Lee
Tu Lee, PhD
Tu Lee
Paul M. Lefebvre
Tracey T. Lefteroff
Tracy T. Lefteroff
Philippe Legoff
Dr. Thomas Lehman
Thomas C. Lehman
Marjorie Lejeune
Andreas Lekebusch
Richard LeLacheur
Bob Lenich
David J. Lennard
Ian C. Lennon
Thomas W. Leonard
Andrea Leone-Bay
John Lepore
Stephen Lermer
Mark Lesher
Galit Levin
Michael Levin
Marina Levina
Carl Levoguer
Richard Levy
Nancy Lewen
David Lewis
Jerry Lewis
John Lewis
Jonathan M. Lewis
Neal A. Lewis
Norma Leyva
H. Li
Hua Li, PhD
Michael Li
Nai-Hong Li
Q. Chan Li
Youngfu Li
Z. Jane Li
Larry Lian
Kong Liang
Peihong Liang
Mark R. Lidell
Jakob Liderfelt
Rachel Lieberman
EMC Life Sciences
Pall Life Sciences Chromatography Technical Team
I Holland Limited
David Lin
Back to Top

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here